chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tinnitus.  I have had a very mild, low-grade case of tinnitus for several years but over the last several months it has become exponentially worse.  It was somewhat gradual after the initial 2 doses of the Pfizer shot but it became severe after the Moderna booster shot in November.  Today, it is very severe. I've tried changes in diet, which do help, but it is still really bad.  I have not attended any loud events or been in any situation that could have worsened the condition.  It is only recently that I have begun to zero in on the covid shots as the likely culprit.
This case was reported by a pharmacist via call center representative and described the occurrence of maculopapular rash in a 66-year-old female patient who received SHINGRIX (batch number 3NY5G, expiry date 7th March 2021) for prophylaxis. Concomitant products included montelukast sodium and loratadine. On 8th February 2019, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 11th February 2019, 3 days after receiving SHINGRIX, the patient experienced maculopapular rash. On an unknown date, the outcome of the maculopapular rash was unknown. It was unknown if the reporter considered the maculopapular rash to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX vaccine on right deltoid. At the time of this report, the patient was experiencing macular papular rash on her neck, abdomen, legs, arms and back. No further details were provided.
Allergic reaction to Pneumonia vaccine. Injection site redness, itching, swelling (softball size), fatigue, high fever 102F, muscle aches, joint pain, nausea, vomiting, diarrhea, elevated CRP.
booster dose; back pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose), for COVID-19 immunisation; Bnt162b2 (2nd dose), for COVID-19 immunisation. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "booster dose"; BACK PAIN (non-serious), outcome "unknown", described as "back pain".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
w/in 12hr of vax pt devel an inj site rxn characterized by tenderness & a 2inch by 2inch welt;pt improving as of 29OCT;this is 1 of 5 pt, out of 12 vaccines, to exp this event;
Eyes dried out, became very red for full 48 hours. Pain all over body severe pain, took MOTRIN, had minimal relief.
Vaccine was administered on 10/05/2021, vaccine expired 10/01/2021
Acute sharp joint pain & stiffness, muscled aching, headache & lethargy.  Started this morning (~12hrs after Vaccine & has persisted all day). Sharp shooting pains in joints & aching muscles while at rest & with movement. Intermittent
dizzy; feverish; tired and feel drained; chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (dizzy), PYREXIA (feverish), FATIGUE (tired and feel drained) and CHILLS (chills) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 001b21A) for COVID-19 vaccination.     The patient's past medical history included Surgery. Concomitant products included LISINOPRIL, COLECALCIFEROL, UBIDECARENONE (COQ10 + D3), ACETYLSALICYLIC ACID (BABY ASPIRIN) and IBUPROFEN for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced DIZZINESS (dizzy), PYREXIA (feverish), FATIGUE (tired and feel drained) and CHILLS (chills). At the time of the report, DIZZINESS (dizzy), PYREXIA (feverish), FATIGUE (tired and feel drained) and CHILLS (chills) was resolving. Not Provided          Patient said he took his regular medications before he left to get the shot. Patient has been taking since he got his shoulder surgery a year ago.
Rash that started on face and spread to rest of body over 3 days.  Rash was accompanied by a fever ranging from 100 - 103 degrees.  Rash and fever lasted for 3 days.
2 hours after administration, patient was stretching arm, when arm went numb and tingly which then radiated to chest, other arm then head.  Patient then had tunnel visition, LOC and observer said she was convulsing for about 10 seconds.  Now patient fatigued.  Soreness at administration site.
Pfizer booster shot; after that shot, I developed an onset of tinnitus and its been with me ever since; it's a radiator is going on in my head; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 18Nov2021 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series complete:, Unknown manufacturer), for Covid-19 immunization. The following information was reported: TINNITUS (non-serious) with onset 18Nov2021, outcome "unknown", described as "Pfizer booster shot; after that shot, I developed an onset of tinnitus and its been with me ever since; it's a radiator is going on in my head".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200759702 Same reporter and drug, different patient
23OCT92 pt recvd vax & that evening spiked t102-104 on the 3rd day of the temp pt was hospitalized;
Eczema; Rash on my leg, on the top of my front side and it was like itchy; This is a spontaneous report from a contactable consumer. This 63-years-old female consumer reported for herself that she received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/lot number: E19266), via an unspecified route of administration on 16Feb2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 21Feb2021, the patient got like a little rash on her leg, on the top of her front side and it was like very itchy. She thought it was little bit of eczema. The patient took cortisone cream over the counter for the event. The outcome of the event eczema was resolved In 2021 whereas other event was resolving.
covid arm; hot; blood sugar level is always low said that it went down to 40 which his usual is from 70-80(Patient is diabetic); Arm soreness; red; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (covid arm), VACCINATION SITE WARMTH (hot), BLOOD GLUCOSE DECREASED (blood sugar level is always low said that it went down to 40 which his usual is from 70-80(Patient is diabetic)), MYALGIA (Arm soreness) and VACCINATION SITE ERYTHEMA (red) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]), CANAGLIFLOZIN (INVOKANA [CANAGLIFLOZIN]) and METFORMIN for an unknown indication.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced HYPERSENSITIVITY (covid arm), VACCINATION SITE WARMTH (hot), BLOOD GLUCOSE DECREASED (blood sugar level is always low said that it went down to 40 which his usual is from 70-80(Patient is diabetic)), MYALGIA (Arm soreness) and VACCINATION SITE ERYTHEMA (red). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Pain in arm, at a dose of 1 dosage form. At the time of the report, HYPERSENSITIVITY (covid arm), VACCINATION SITE WARMTH (hot), BLOOD GLUCOSE DECREASED (blood sugar level is always low said that it went down to 40 which his usual is from 70-80(Patient is diabetic)), MYALGIA (Arm soreness) and VACCINATION SITE ERYTHEMA (red) outcome was unknown.            Patient took Benadryl for sore arm and diabetic medications.
pt recv vax 10APR97 & 6JUN97 pt devel chickenpox w/15 lesions;
Severe muscle spams in lower back, painful but not debilitating, took some Advil at noon and beginning to get around much better. Had trouble getting out of bed this AM but walking Ok with discomfort now.
Patient tested positive for COVID-19 on 25Jan2022 or 26Jan2022. Reports minor symptoms. No additional information was provided by reporter on symptoms.; Patient tested positive for COVID-19 on 1/25 or 1/26/22. Reports minor symptoms. No additional information was provided by reporter on symptoms.; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  An adult male patient received bnt162b2 (BNT162B2), administration date Dec2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), administration date: Jan2021, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), administration date: Jan2021, for COVID-19 immunization.  The following information was reported: DRUG INEFFECTIVE (medically significant) with onset Jan2022, outcome "unknown", described as "Patient tested positive for COVID-19 on 25Jan2022 or 26Jan2022. Reports minor symptoms. No additional information was provided by reporter on symptoms."; COVID-19 (medically significant) with onset Jan2022, outcome "unknown", described as "Patient tested positive for COVID-19 on 1/25 or 1/26/22. Reports minor symptoms. No additional information was provided by reporter on symptoms.". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Jan2022) positive.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
she has limited ROM / cannot lay on her right side / cannot lie on that arm; she normally feels sore, but not this long / cannot lie on that arm / still in pain; This case was reported by a other health professional and described the occurrence of injected limb mobility decreased in a female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 33AT7, expiry date 7th November 2022) for prophylaxis.   On 6th October 2020, the patient received Boostrix. On 13th October 2020, 7 days after receiving Boostrix, the patient experienced injected limb mobility decreased and pain in arm. The patient was treated with antiinflammatory/antirheumatic products (Anti Inflammatory Drug (Nos)). On an unknown date, the outcome of the injected limb mobility decreased and pain in arm were recovering/resolving.   It was unknown if the reporter considered the injected limb mobility decreased and pain in arm to be related to Boostrix.  Additional details were provided as follows: This case was reported by office manager. The age at vaccination was not reported The patient received Boostrix on the right deltoid. The reporter stated that the patient called the office on 13th October 2020 stating that she had limited range of motion (ROM) and could not lay on her right side. She was concerned since she normally felt sore, but not this long.  The physician evaluated the patient on 13th October 2020. Pain had not improved. No redness or swelling or fever, but could not lie on that arm. The reporter spoke to the patient on 18th October 2020 and she was still in pain even after taking anti inflammatories. The patient went to get an US or the arm which was normal. The patient then had an MRI to look into further. On 27th October 2020, the patient's pain had decreased significantly and ROM had improved. MRI was not done. This case was linked with US2021AMR005709 and US2020AMR252163, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR252163:same reporter US-GLAXOSMITHKLINE-US2021AMR005709:same reporter
right leg swelled; difficulty in walking; This is a spontaneous report received from a contactable consumer (patient). A patient of an unspecified gender in 70s received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/lot number and expiration date were not reported), via an unspecified route of administration in the left arm (reported as left shoulder) on an unspecified date as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the next morning, patient experienced right leg swelled to point of difficulty in walking. Patient needed assistance. It was reported that the patient never had such a reaction to any vaccine ever in the past. Paracetamol (Tylenol) was taken for the events but seems to have done nothing for the swelling. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a pharmacist refers to a 21 year old male patient. Information regarding patient's medical history, concurrent conditions and concomitant medications were unknown. There were no drug reactions/allergies. On 28-SEP-2016, the patient was vaccinated with a dose of PNEUMOVAX 23 (dosing details, lot # and expiration date unspecified) via subcutaneous route. Pharmacist reported that on an unknown date after vaccination, the patient complained of pain at the injection site that was radiating to the underside of the arm. The patient required medical attention and was treated with Ibuprofen and ice for the pain. Her present status was unknown. Reporting pharmacist had not assessed the causality of the event with respect to therapy with PNEUMOVAX 23. Additional information has been requested.
Stye in right eye; Painful eyelid; swelling of eyelid; eyelid turned red; eyes are itchy; Tip of eyelid there was pus pimple; Scratchy; Drainage; Crustiness; headaches; This spontaneous case was reported by a consumer and describes the occurrence of HORDEOLUM (Stye in right eye), EYELID PAIN (Painful eyelid), SWELLING OF EYELID (swelling of eyelid), ERYTHEMA OF EYELID (eyelid turned red) and EYE PRURITUS (eyes are itchy) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stye and Surgery (Retinal surgery for retinal tears in the past in both eyes.).   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced HEADACHE (headaches). On 24-Apr-2021, the patient experienced HORDEOLUM (Stye in right eye), EYELID PAIN (Painful eyelid), SWELLING OF EYELID (swelling of eyelid), ERYTHEMA OF EYELID (eyelid turned red), EYE PRURITUS (eyes are itchy), ACNE (Tip of eyelid there was pus pimple), EYE PRURITUS (Scratchy), LACRIMATION INCREASED (Drainage) and EYELID MARGIN CRUSTING (Crustiness). At the time of the report, HORDEOLUM (Stye in right eye), EYELID PAIN (Painful eyelid), SWELLING OF EYELID (swelling of eyelid), ERYTHEMA OF EYELID (eyelid turned red), EYE PRURITUS (eyes are itchy), ACNE (Tip of eyelid there was pus pimple), EYE PRURITUS (Scratchy), LACRIMATION INCREASED (Drainage), EYELID MARGIN CRUSTING (Crustiness) and HEADACHE (headaches) outcome was unknown.            No concomitant medications were provided. Treatment reported includes  Warm compressions. She wears contacts and had retinal surgery for retinal tears in the past in both eyes.   This case was linked to MOD-2021-071890 (Patient Link).
within 12hrs of receiving his second Moderna patient states that he tasted a penny taste in mouth and then coughed up blood for the next 4hrs after, patient denies any facial injury/mouth injury at the time; patient also had all of the normal side effects after receiving the COVID vaccine.
On 9/8/16, I woke up with tingling in my lower lip. Within a few hours the entire lower half of my face was numb, including tongue, teeth, lips, jaw, chin. The strength of the numbness would come and go over the next few days and then on 9/13/16, the numbness began to migrate around my body. It would be in my right ear (deep numbness, not surface/skin), then my left hand and thumb, then my left foot - which also had a stabbing pain and I couldn't move my two small toes, then my kidney area, my stomach, my chest, forehead, etc. I would feel the deep numbness for about 20-30 minutes in one area before it would go somewhere else in my body. It didn't seem to have any rhyme or reason. After a full day's rest the next day, I began to improve, however, the numbness in my tongue never fully went away and some days I would have the migrating numbness. On October 14th, my symptoms began to increase again, however, it was not just one place at a time. I had numbness from the back of my nose, down my throat, to my stomach, and down to between my legs - all at once. By 1:00am the 15th, the numbness in my torso got stronger and was accompanied by intense pain. I felt my stomach was cramping/hardening. It then added my right ear, which was also accompanied by pain. To date October 18th, the numbness has not subsided and is always accompanied by pain.
Patient became dizziness and nauseated. S/S did not improve over 30 minutes.
administration of only the liquid component; administration of only the liquid component; This case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 18-March-2022 Reporter's comment: The reporter had called to request information on inadvertent administration of only the liquid component (menCWY) of Menveo. Additional supportive information: The patient inadvertently administered only the liquid component of Menveo, which led to Inappropriate preparation of medication and Inappropriate dose of vaccine administered. This case had been linked with case US2022AMR083216, reported by the same facility.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR083216:Same facility
Within 5 minutes of shot, diarrhea and severe stomach cramps, sensitive to light and sound 5:30pm chills, temp 97.8  7:00pm warm shower 7:15pm diarrhea, shortness of breath, sweat dripping down body, dizzy, nauseated  7:45pm cool compresses on head and neck, clams, shortness of breath, still dizzy, weakened began shacking. 7:55pm. Dressed by husband and put in bed. Temperature 90.0 8:00pm 3 blankets on me, gloves on, socks and slippers on and heating pads to ankles and feet, still dizzy and shacking. no circulation to hand or feet. no capillary refill. 8:30pm Called nurse on Call who stayed on the phone with me for 45 minutes, two Advil taken. Trying to eat crackers and hydrate. 8:45pm. feeling blood flowing to hands but not feet. 9:45pm gloves off hands and heavy blanket off, toes still ice cold.10:15pm Up to bathroom with husbands help, no strength. Urinated, no more diarrhea. Stomach still making a lot of noise. Still sensitive to light and sound, feeling to toes, still dizzy.11:30pm Feeling more like myself. Just exhausted. Slept off and on throughout the night and hydrated and up to urinate on my own without assistance. Jan. 14, 2021 , 10:00am- Sitting up in bed. Very tired. Drinking water. 12:00 noon able to eat an egg and avocado sandwich
It has a burning sensation; pain sensation; feels warm to touch; I noticed a red lesion at the site of the injection; sore arm for 3/4 days; occasional chills; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (It has a burning sensation), PAIN (pain sensation), FEELING HOT (feels warm to touch), MYALGIA (sore arm for 3/4 days) and CHILLS (occasional chills) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jul-2021, the patient experienced MYALGIA (sore arm for 3/4 days) and CHILLS (occasional chills). On 07-Aug-2021, the patient experienced VACCINATION SITE ERYTHEMA (I noticed a red lesion at the site of the injection). On 08-Aug-2021, the patient experienced BURNING SENSATION (It has a burning sensation), PAIN (pain sensation) and FEELING HOT (feels warm to touch). At the time of the report, BURNING SENSATION (It has a burning sensation), PAIN (pain sensation), FEELING HOT (feels warm to touch) and VACCINATION SITE ERYTHEMA (I noticed a red lesion at the site of the injection) outcome was unknown and MYALGIA (sore arm for 3/4 days) and CHILLS (occasional chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant history was not reported. The treatment history was not provided.
pt recvd vax; devel skin redness & swollen arm; md reported that pt had hot & tender arm;md did not have any info regarding pt;
pt recv vax 9OCT96 & bell's palsy 24OCT96;rt facial paralysis;
Pt exp fever 104.6 mom had been giving APAP, pt drinking po fluids well but appetite poor; seen in ER;
Within minutes, I experienced tachycardia and syncope with weakness.   After 30+ minutes, they cleared me to go home with no intervention.  My heart rate had come down and though still weak they felt I was ok.  Hives began within this period and worsened after my release.  Nausea and dizziness within the hour which persisted for 5 days with fevers, chills and sweats, until diarrhea became the predominant stomach ache.  Through the first three days, chest pain and weakness continued with the dizziness, fevers and nausea.  Metallic taste in mouth.  Blister on roof of mouth.  Lymph node swelling under arm within a day or so, and into the neck by day 6.  Very tender.  Fevers continue but low grade and without chills or sweats.  Right eye pain beginning first night -continuing still.  Episodic hives first several days.  Joint pain, nerve pain, muscle pain. Bright red joints and tendons episodically.
IT HAS BEEN OVER 1 MONTH SINCE I RECEIVED MY 2ND DOSE AND MY INJECTION SITE IS STILL SORE AND ITCHY.  THERE IS STILL A SMALL BUMP WHERE THE NEEDLE PUNCTURED MY SKIN.